Abstract
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is common and influences the activity-dependent secretion of BDNF, which is critical for neuronal plasticity and survival. This study investigated the genetic effect of the BDNF Val66Met polymorphism on cognitive function and regional gray matter (GM) volume in a healthy Chinese population (n = 330). Voxel-based morphometry (VBM)-optimized analysis was used. There was no significant difference in the neuropsychological performances among the three BDNF genotypic groups. VBM analyses demonstrated that Met homozygotes had greater GM volumes than Val homozygotes in the left medial frontal gyrus, the left middle temporal gyrus, the left cerebellum, and the right middle temporal gyrus, and had larger GM volumes than Val/Met heterozygotes in the left middle temporal gyrus, the left inferior temporal gyrus, and the right superior frontal gyrus. Our findings suggest that the presence of two Met alleles has a protective effect on regional GM volumes in the Chinese population.
Similar content being viewed by others
References
Aicardi, G., Argilli, E., Cappello, S., Santi, S., Riccio, M., Thoenen, H., et al. (2004). Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain derived neurotrophic factor. Proceedings of the National Academy of Sciences of the United States of America, 101(44), 15788–15792.
Ashburner, J. (2007). A fast diffeomorphic image registration algorithm. Neuroimage, 38(1), 95–113.
Ashburner, J., & Friston, K. J. (2000). Voxel-based morphometry–the methods. Neuroimage, 11(6 Pt 1), 805–821.
Ashburner, J., & Friston, K. J. (2005). Unified segmentation. Neuroimage, 26(3), 839–851.
Bueller, J. A., Aftab, M., Sen, S., Gomez-Hassan, D., Burmeister, M., & Zubieta, J. K. (2006). BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biological Psychiatry, 59(9), 812–815.
Carballedo, A., Amico, F., Ugwu, I., Fagan, A. J., Fahey, C., Morris, D., et al. (2012). Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159B(5), 537–548.
Carballedo, A., Morris, D., Zill, P., Fahey, C., Reinhold, E., Meisenzahl, E., et al. (2013). Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162B(2), 183–190.
Chen, Q. Y., Chen, Q., Feng, G. Y., Wan, C. L., Lindpaintner, K., Wang, L. J., et al. (2006). Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neuroscience Letters, 397(3), 285–290.
Cuadra, M. B., Cammoun, L., Butz, T., Cuisenaire, O., & Thiran, J. P. (2005). Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Transactions on Medical Imaging, 24(12), 1548–1565.
Dempster, E., Toulopoulou, T., McDonald, C., Bramon, E., Walshe, M., Filbey, F., et al. (2005). Association between BDNF val66 met genotype and episodic memory. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 134B(1), 73–75.
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2), 257–269.
Gajewski, P. D., Hengstler, J. G., Golka, K., Falkenstein, M., & Beste, C. (2011). The Met-allele of the BDNF Val66Met polymorphism enhances task switching in elderly. Neurobiology of Aging, 32(12), 2327.e7–2327.e19.
Goldberg, T. E., Iudicello, J., Russo, C., Elvevag, B., Straub, R., Egan, M. F., et al. (2008). BDNF Val66Met polymorphism significantly affects d′ in verbal recognition memory at short and long delays. Biological Psychology, 77(1), 20–24.
Gonul, A. S., Kitis, O., Eker, M. C., Eker, O. D., Ozan, E., & Coburn, K. (2011). Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. The World Journal of Biological Psychiatry, 12(2), 110–118.
Gorski, J. A., Balogh, S. A., Wehner, J. M., & Jones, K. R. (2003). Learning deficits in forebrain-restricted brain derived neurotrophic factor mutant mice. Neuroscience, 121(2), 341–354.
Guo, N. W., Liu, H. C., Wong, P. F., Liao, K. K., Yan, S. H., Lin, K. P., et al. (1988). Chinese version and norms of the mini-mental status examination. Chinese Journal of Rehabilitation Medicine, 16, 52–59.
Hajek, T., Kopecek, M., & Höschl, C. (2012). Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: Meta-analysis. The World Journal of Biological Psychiatry, 13(3), 178–187.
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., & Egan, M. F. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. The Journal of Neuroscience, 23(17), 6690–6694.
Harris, S. E., Fox, H., Wright, A. F., Hayward, C., Starr, J. M., & Whalley, L. J. (2006). The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Molecular Psychiatry, 11(5), 505–513.
Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., & Barde, Y. A. (1990). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. The EMBO Journal, 9(8), 2459–2464.
Joffe, R. T., Gatt, J. M., Kemp, A. H., Grieve, S., Dobson-Stone, C., Kuan, S. A., et al. (2009). Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness. Human Brain Mapping, 30(4), 1246–1256.
Kambeitz, J. P., Bhattacharyya, S., Ilankovic, L. M., Valli, I., & Collier, D. A. (2012). Effect of BDNF Met66Val-Polymorphism on declarative memory and its neural substrate: A meta-analysis. Neuroscience and Biobehavioral Reviews, 36(9), 2165–2177.
Karnik, M. S., Wang, L., Barch, D. M., Morris, J. C., & Csernansky, J. G. (2010). BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Research, 178(2), 425–429.
Koolschijn, P. C., van Haren, N. E., Bakker, S. C., Hoogendoorn, M. L., Hulshoff Pol, H. E., & Kahn, R. S. (2010). Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus, 20(9), 1010–1017.
Korte, M., Griesbeck, O., Gravel, C., Carroll, P., Staiger, V., Thoenen, H., et al. (1996). Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 93(22), 12547–12552.
Lang, U. E., Hellweg, R., Kalus, P., Bajbouj, M., Lenzen, K. P., Sander, T., et al. (2005). Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl), 180(1), 95–99.
Lau, J. Y., Goldman, D., Buzas, B., Hodgkinson, C., Leibenluft, E., Nelson, E., et al. (2010). BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. Neuroimage, 53(3), 952–961.
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001). Regulation of cell survival by secreted proneurotrophins. Science, 294(5548), 1945–1948.
Li, J., Yu, C., Li, Y., Liu, B., Liu, Y., Shu, N., et al. (2009). COMT val158met modulates association between brain white matter architecture and IQ. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B(3), 375–380.
Lu, B. (2003). BDNF and activity-dependent synaptic modulation. Learning & Memory, 10(2), 86–98.
Manjon, J. V., Coupe, P., Marti-Bonmati, L., Collins, D. L., & Robles, M. (2010). Adaptive non-local means denoising of MR images with spatially varying noise levels. Journal of Magnetic Resonance Imaging: JMRI, 31(1), 192–203.
Meyer-Lindenberg, A., & Weinberger, D. R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience, 7(10), 818–827.
Molendijk, M. L., Bus, B. A., Spinhoven, P., Kaimatzoglou, A., Voshaar, R. C., Penninx, B. W., et al. (2012). A systematic review and meta-analysis on the association between BDNF val(66) met and hippocampal volume-A genuine effect or a winners curse? American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159B(6), 731–740.
Montag, C., Basten, U., Stelzel, C., Fiebach, C. J., & Reuter, M. (2010a). The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans. Psychiatry Research, 179(1), 86–90.
Montag, C., Reuter, M., Newport, B., Elger, C., & Weber, B. (2008). The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: Evidence from a genetic imaging study. Neuroimage, 42(4), 1554–1559.
Montag, C., Schoene-Bake, J. C., Faber, J., Reuter, M., & Weber, B. (2010b). Genetic variation on the BDNF gene is not associated with differences in white matter tracts in healthy humans measured by tract-based spatial statistics. Genes, Brain and Behavior, 9(8), 886–891.
Montag, C., Weber, B., Fliessbach, K., Elger, C., & Reuter, M. (2009). The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: Incremental support for a genetic risk factor for depression. Psychological Medicine, 39(11), 1831–1839.
Nemoto, K., Ohnishi, T., Mori, T., Moriguchi, Y., Hashimoto, R., Asada, T., et al. (2006). The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neuroscience Letters, 397(1–2), 25–29.
Neves-Pereira, M., Cheung, J. K., Pasdar, A., Zhang, F., Breen, G., Yates, P., et al. (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry, 10(2), 208–212.
Oroszi, G., Lapteva, L., Davis, E., Yarboro, C. H., Weickert, T., Roebuck-Spencer, T., et al. (2006). The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 65(10), 1330–1335.
Petryshen, T. L., Sabeti, P. C., Aldinger, K. A., Fry, B., Fan, J. B., Schaffner, S. F., et al. (2010). Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Molecular Psychiatry, 15(8), 810–815.
Pezawas, L., Meyer-Lindenberg, A., Goldman, A. L., Verchinski, B. A., Chen, G., Kolachana, B. S., et al. (2008). Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Molecular Psychiatry, 13(7), 709–716.
Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., et al. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. The Journal of Neuroscience, 24(45), 10099–10102.
Poo, M. M. (2001). Neurotrophins as synaptic modulators. Nature Reviews Neuroscience, 2(1), 24–32.
Rajapakse, J. C., Giedd, J. N., & Rapoport, J. L. (1997). Statistical approach to segmentation of single-channel cerebral MR images. IEEE Transactions on Medical Imaging, 16(2), 176–186.
Ramasamy, D. P., Ramanathan, M., Cox, J. L., Antulov, R., Weinstock-Guttman, B., Bergsland, N., et al. (2011). Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study. Pathophysiology, 18(1), 53–60.
Reitan, M., & Wolfson, D. (1985). The Halstead–Reitan neuropsychological test battery: Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press.
Rosa, A., Cuesta, M. J., Fatjo-Vilas, M., Peralta, V., Zarzuela, A., & Fañanás, L. (2006). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: Evidence from a family-based association study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(2), 135–138.
Seidah, N. G., Benjannet, S., Pareek, S., Chretien, M., & Murphy, R. A. (1996). Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Letters, 379(3), 247–250.
Sen, S., Nesse, R. M., Stoltenberg, S. F., Li, S., Gleiberman, L., Chakravarti, A., et al. (2003). A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology, 28(2), 397–401.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (MINI.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22–33.
Studer, L., Spenger, C., Seiler, R. W., Othberg, A., Lindvall, O., & Odin, P. (1996). Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon. Experimental Brain Research, 108(2), 328–336.
Szeszko, P. R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., et al. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry, 10(7), 631–636.
Takahashi, T., Suzuki, M., Tsunoda, M., Kawamura, Y., Takahashi, N., Maeno, N., et al. (2008). The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(5), 1236–1242.
Talairach, J., & Tornoux, P. (1998). Co-planar stereotaxic atlas of the human brain: 3-Dimensional proportional system: An approach to cerebral imaging. Stuttgart: Georg Thieme.
Tan, H. Y., Chen, A. G., Chen, Q., Browne, L. B., Verchinski, B., Kolachana, B., et al. (2012). Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications. Molecular Psychiatry, 17(10), 1007–1016.
Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008). New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews, 59(1), 201–220.
Tohka, J., Zijdenbos, A., & Evans, A. (2004). Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage, 23(1), 84–97.
Tost, H., Alam, T., Geramita, M., Rebsch, C., Kolachana, B., Dickinson, D., et al. (2012). Effects of the BDNF Val66Met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacology, 38(3), 525–532.
Tsai, S. J., Gau, Y. T., Liu, M. E., Hsieh, C. H., Liou, Y. J., & Hong, C. J. (2008). Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Neuroscience Letters, 433(2), 158–162.
Ventriglia, M., Bocchio Chiavetto, L., Benussi, L., Binetti, G., Zanetti, O., Riva, M. A., et al. (2002). Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Molecular Psychiatry, 7(2), 136–137.
Voineskos, A. N., Lerch, J. P., Felsky, D., Shaikh, S., Rajji, T. K., Miranda, D., et al. (2011). The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Archives of General Psychiatry, 68(2), 198–206.
Willis-Owen, S. A., Fullerton, J., Surtees, P. G., Wainwright, N. W., Miller, S., & Flint, J. (2005). The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism. Biological Psychiatry, 58(9), 738–742.
Yamada, K., Mizuno, M., & Nabeshima, T. (2002). Role for brain-derived neurotrophic factor in learning and memory. Life Sciences, 70(7), 735–744.
Yang, X., Liu, P., Sun, J., Wang, G., Zeng, F., Yuan, K., et al. (2012). Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One, 7(6), e37777.
Yu, H., Zhang, Z., Shi, Y., Bai, F., Xie, C., Qian, Y., et al. (2008). Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. The Journal of Clinical Psychiatry, 69(7), 1104–1111.
Acknowledgments
This work was supported by Grants V101C-006 from Taipei Veterans General Hospital, Taiwan, and Grant NSC 101-2314-B-075-040, NSC 100-2628-E-010-002-MY3 and NSC 101-2321-B-010-026 from National Science Council Grant, Taiwan. We thank Ms Ashley for English editing.
Conflict of interest
All authors have no actual or potential conflicts of interest within 3 years of beginning the work submitted that could inappropriately influence the work.
Ethical standard
This study was approved by the Institutional Review Board of Taipei Veterans General Hospital. Informed consent was obtained from all subjects prior to commencement.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Liu, ME., Huang, CC., Chen, MH. et al. Effect of the BDNF Val66Met Polymorphism on Regional Gray Matter Volumes and Cognitive Function in the Chinese Population. Neuromol Med 16, 127–136 (2014). https://doi.org/10.1007/s12017-013-8265-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-013-8265-7